DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN FOR ATRIAL FIBRILLATION IN FRAIL AND NON-FRAIL PATIENTS

Authors :: Mituru Yoshino
Masatomo Ozaki
Kazushige Kadota
Noriyuki Ohashi
Hiroshi Tasaka
Reo Hata
Source :: Journal of the American College of Cardiology. 71:A286
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.
Abstract: Impact of direct oral anticoagulants (DOAC) on frail and non-frail patients with atrial fibrillation (AF), in comparison with that of warfarin is unknown. We enrolled 1209 consecutive AF patients between January 2013 and December 2015. Of whom, 486 elderly patients, including 436 patients receiving

Subjects :: 0301 basic medicine
medicine.medical_specialty
business.industry
health care facilities, manpower, and services
Warfarin
Atrial fibrillation
030204 cardiovascular system & hematology
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Internal medicine
Medicine
Cardiology and Cardiovascular Medicine
business
human activities
medicine.drug

Full Text Access

Tools